On the recordNovember 29, 2012
It is outlining NIH's and specifically the National Cancer Institute's concerns with this type of directive from us. I think they care about whether we solve these problems associated with these recalcitrant cancers. I think people who want to get it solved are true in their motives to try to solve it. But there are some significant things in his letter that I would like to quote for my colleagues because I think it might just change your mind about us micromanaging what they are doing. First, he says: We have all the authorities to do whatever we need to do with the money that you have given us. We can do all these things you want us to do. If you tell us to do them, we will do them. But we already have the authority to go where we think we are going to get the best results in the quickest way. NIH constantly examines scientific opportunities and conducts research evaluation and planning opportunities within its current statutory In other words they are looking, trying to figure out how they change, where they go now The national cancer institute recently organized a group to provide a ``horizon scan'' of pancreatic ductal adenocarcinoma ad carcinoma, building on previous planning They just did all this. They have just been through a total review of pancreatic adenocarcinoma, and they have just shifted where they are spending funds to address this issue.…





